A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory Conditions

June 1, 1998
Michael T. Halpern, MD, PhD
Michael T. Halpern, MD, PhD

,
Cynthia S. Palmer, MSc
Cynthia S. Palmer, MSc

,
C. Stephen Foster, MD
C. Stephen Foster, MD

,
Ashish Pal, BS Pharm, MBA
Ashish Pal, BS Pharm, MBA

,
Carmelina Battista, PharmD
Carmelina Battista, PharmD

Volume 4, Issue 6